ADAR1 Capital Management, LLC

13D and 13G Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.

Issuer	Symbol	CUSIP	% of Class	Shares	Form	Filed
InMed Pharmaceuticals, Inc. 13G/A Amendment 1 INM · 457637700	INM	457637700	17.2%	943,668	13G/A Amendment 1	10/7/2026 Event 9/30/2026
ADAR1 Capital Management, LLC			17.2%	943,668
Daniel Schneeberger			17.2%	943,668
Tenax Therapeutics, Inc. 13G TENX · 88032L605	TENX	88032L605	14.0%	5,257,389	13G	9/8/2026 Event 8/31/2026
ADAR1 Capital Management, LLC			14.0%	5,257,389
Daniel Schneeberger			14.0%	5,257,389
NextCure, Inc. 13G NXTC · 65343E207	NXTC	65343E207	15.8%	722,419	13G	8/14/2026 Event 7/31/2026
ADAR1 Capital Management, LLC			15.8%	722,419
Daniel Schneeberger			15.8%	722,419
Yarrow Bioscience, Inc. 13G YARW · 92941V407	YARW	92941V407	8.8%	59,000	13G	8/14/2026 Event 6/30/2026
ADAR1 Capital Management, LLC			8.8%	59,000
Daniel Schneeberger			8.8%	59,000
Rein Therapeutics, Inc. 13G RNTX · 00887A204	RNTX	00887A204	5.3%	4,500,000	13G	8/14/2026 Event 6/30/2026
ADAR1 Capital Management, LLC			5.3%	4,500,000
Daniel Schneeberger			5.3%	4,500,000
Research Alliance Corporation III 13G RACC · G75226103	RACC	G75226103	8.4%	650,000	13G	8/14/2026 Event 6/30/2026
ADAR1 Capital Management, LLC			8.4%	650,000
Daniel Schneeberger			8.4%	650,000
Pliant Therapeutics, Inc. 13G PLRX · 729139105	PLRX	729139105	8.9%	5,509,724	13G	8/14/2026 Event 6/30/2026
ADAR1 Capital Management, LLC			8.9%	5,509,724
Daniel Schneeberger			8.9%	5,509,724
JATT II Acquisition Corp. 13G JATT · G50765109	JATT	G50765109	5.4%	417,724	13G	8/14/2026 Event 6/30/2026
ADAR1 Capital Management, LLC			5.4%	417,724
Daniel Schneeberger			5.4%	417,724
Editas Medicine, Inc. 13G EDIT · 28106W103	EDIT	28106W103	5.8%	8,889,000	13G	8/14/2026 Event 6/30/2026
ADAR1 Capital Management, LLC			5.8%	8,889,000
Daniel Schneeberger			5.8%	8,889,000
Cyclerion Therapeutics, Inc. 13G CYCN · 23255M204	CYCN	23255M204	7.0%	298,757	13G	8/14/2026 Event 6/30/2026
ADAR1 Capital Management, LLC			7.0%	298,757
Daniel Schneeberger			7.0%	298,757
Boundless Bio, Inc. 13G BOLD · 10170A100	BOLD	10170A100	8.8%	1,968,216	13G	8/14/2026 Event 6/30/2026
ADAR1 Capital Management, LLC			8.8%	1,968,216
Daniel Schneeberger			8.8%	1,968,216
Amanat Acquisition Corp. 13G AMAN · G0375M101	AMAN	G0375M101	9.6%	750,000	13G	8/14/2026 Event 6/30/2026
ADAR1 Capital Management, LLC			9.6%	750,000
Daniel Schneeberger			9.6%	750,000
Ovid Therapeutics Inc. 13G/A Amendment 1 OVID · 690469101	OVID	690469101	5.1% Checked 5% or less	9,559,979	13G/A Amendment 1	8/14/2026 Event 6/30/2026
ADAR1 Capital Management, LLC			5.1%	9,559,979
ADAR1 Capital Management GP, LLC			4.9%	9,122,588
Daniel Schneeberger			5.1%	9,559,979
Adagio Medical Holdings, Inc. 13G/A Amendment 1 ADGM · 00534B100	ADGM	00534B100	5.4%	1,205,447	13G/A Amendment 1	8/14/2026 Event 6/30/2026
ADAR1 Capital Management, LLC			5.4%	1,205,447
Daniel Schneeberger			5.4%	1,205,447
Grace Therapeutics, Inc. 13G/A Amendment 6 GRCE · 00439U104	GRCE	00439U104	9.9%	1,806,216	13G/A Amendment 6	8/14/2026 Event 6/30/2026
ADAR1 Capital Management, LLC			9.9%	1,806,216
ADAR1 Capital Management GP, LLC			8.6%	1,525,757
Daniel Schneeberger			9.9%	1,806,216
OnKure Therapeutics, Inc. 13G/A Amendment 2 OKUR · 68277Q105	OKUR	68277Q105	5.5% Checked 5% or less	2,238,684	13G/A Amendment 2	8/14/2026 Event 6/30/2026
ADAR1 Capital Management, LLC			5.5%	2,238,684
ADAR1 Capital Management GP, LLC			4.5%	1,832,117
Daniel Schneeberger			5.5%	2,238,684
Kiora Pharmaceuticals, Inc. 13G/A Amendment 2 KPRX · 49721T507	KPRX	49721T507	9.9%	475,378	13G/A Amendment 2	8/14/2026 Event 6/30/2026
ADAR1 Capital Management, LLC			9.9%	472,721
ADAR1 Capital Management GP, LLC			9.9%	475,378
Daniel Schneeberger			9.9%	472,721
Freenome, Inc. 13G/A Amendment 2 FRNM · 35661P100	FRNM	35661P100	8.3%	674,695	13G/A Amendment 2	8/14/2026 Event 6/30/2026
ADAR1 Capital Management, LLC			8.3%	674,695
ADAR1 Capital Management GP, LLC			6.1%	494,449
Daniel Schneeberger			8.3%	674,695
Spruce Biosciences, Inc. 13G/A Amendment 1 SPRB · 85209E208	SPRB	85209E208	2.5%	67,717	13G/A Amendment 1	8/14/2026 Event 6/30/2026
ADAR1 Capital Management, LLC			2.5%	67,717
Daniel Schneeberger			2.5%	67,717
InMed Pharmaceuticals, Inc. 13G INM · 457637700	INM	457637700	24.1%	800,000	13G	6/5/2026 Event 5/31/2026
ADAR1 Capital Management, LLC			24.1%	800,000
Daniel Schneeberger			24.1%	800,000
Rallybio Corporation 13G RLYB · 75120L209	RLYB	75120L209	17.5%	926,352	13G	6/5/2026 Event 5/31/2026
ADAR1 Capital Management, LLC			17.5%	926,352
Daniel Schneeberger			17.5%	926,352
Equillium, Inc. 13G/A Amendment 1 EQ · 29446K106	EQ	29446K106	9.9%	6,603,754	13G/A Amendment 1	5/15/2026 Event 3/31/2026
ADAR1 Capital Management, LLC			9.9%	6,603,754
ADAR1 Capital Management GP, LLC			9.5%	6,306,184
Daniel Schneeberger			9.9%	6,603,754
OnKure Therapeutics, Inc. 13G/A Amendment 1 OKUR · 68277Q105	OKUR	68277Q105	6.0%	2,434,941	13G/A Amendment 1	5/15/2026 Event 3/31/2026
ADAR1 Capital Management, LLC			6.0%	2,434,941
ADAR1 Capital Management GP, LLC			5.0%	2,038,429
Daniel Schneeberger			6.0%	2,434,941
Quoin Pharmaceuticals, Ltd. 13G/A Amendment 1 QNRX · 74907L409	QNRX	74907L409	4.9%	102,883	13G/A Amendment 1	5/15/2026 Event 3/31/2026
ADAR1 Capital Management, LLC			4.9%	102,846
ADAR1 Capital Management GP, LLC			4.9%	102,883
Daniel Schneeberger			4.9%	102,846
Inhibikase Therapeutics, Inc. 13G/A Amendment 3 IKT · 45719W205	IKT	45719W205	9.9%	13,860,028	13G/A Amendment 3	5/15/2026 Event 3/31/2026
ADAR1 Capital Management, LLC			9.9%	13,860,028
ADAR1 Capital Management GP, LLC			8.5%	11,832,998
Daniel Schneeberger			9.9%	13,860,028
Grace Therapeutics, Inc. 13G/A Amendment 5 GRCE · 00439U104	GRCE	00439U104	9.9%	1,717,426	13G/A Amendment 5	5/15/2026 Event 3/31/2026
ADAR1 Capital Management, LLC			9.9%	1,717,009
ADAR1 Capital Management GP, LLC			9.9%	1,717,426
Daniel Schneeberger			9.9%	1,717,009
LeonaBio, Inc. 13G LONA · 04746L203	LONA	04746L203	7.7%	727,481	13G	5/15/2026 Event 3/31/2026
ADAR1 Capital Management, LLC			7.7%	727,481
Daniel Schneeberger			7.7%	727,481
Helix Acquisition Corp. III 13G HLXC · G4444S107	HLXC	G4444S107	5.6%	1,000,000	13G	5/15/2026 Event 3/31/2026
ADAR1 Capital Management, LLC			5.6%	1,000,000
Daniel Schneeberger			5.6%	1,000,000
Ovid Therapeutics Inc. 13G OVID · 690469101	OVID	690469101	6.9%	9,284,166	13G	2/17/2026 Event 12/31/2025
ADAR1 Capital Management, LLC			6.9%	9,284,166
ADAR1 Capital Management GP, LLC			6.9%	9,284,166
Daniel Schneeberger			6.9%	9,284,166
Spruce Biosciences, Inc. 13G SPRB · 85209E208	SPRB	85209E208	5.4%	58,000	13G	2/17/2026 Event 12/31/2025
ADAR1 Capital Management, LLC			5.4%	58,000
Daniel Schneeberger			5.4%	58,000
OnKure Therapeutics, Inc. 13G OKUR · 68277Q105	OKUR	68277Q105	7.9%	1,014,158	13G	2/17/2026 Event 12/31/2025
ADAR1 Capital Management, LLC			7.9%	1,014,158
ADAR1 Capital Management GP, LLC			6.2%	793,602
Daniel Schneeberger			7.9%	1,014,158
Quoin Pharmaceuticals, Ltd. 13G QNRX · 74907L409	QNRX	74907L409	6.9%	58,230	13G	2/17/2026 Event 12/31/2025
ADAR1 Capital Management, LLC			6.9%	58,230
ADAR1 Capital Management GP, LLC			6.0%	50,226
Daniel Schneeberger			6.9%	58,230
Adagio Medical Holdings, Inc. 13G ADGM · 00534B100	ADGM	00534B100	5.7%	1,205,447	13G	2/17/2026 Event 12/31/2025
ADAR1 Capital Management, LLC			5.7%	1,205,447
Daniel Schneeberger			5.7%	1,205,447
BioAge Labs, Inc. 13G/A Amendment 1 BIOA · 09077V100	BIOA	09077V100	0.4%	135,560	13G/A Amendment 1	2/17/2026 Event 12/31/2025
ADAR1 Capital Management, LLC			0.4%	135,560
Daniel Schneeberger			0.4%	135,560
Inhibikase Therapeutics, Inc. 13G/A Amendment 2 IKT · 45719W205	IKT	45719W205	9.9%	12,692,387	13G/A Amendment 2	2/17/2026 Event 12/31/2025
ADAR1 Capital Management, LLC			9.9%	12,523,371
ADAR1 Capital Management GP, LLC			9.9%	12,692,387
Daniel Schneeberger			9.9%	12,523,371
iBio, Inc. 13G/A Amendment 4 IBIO · 451033708	IBIO	451033708	4.4%	1,351,671	13G/A Amendment 4	2/17/2026 Event 12/31/2025
ADAR1 Capital Management, LLC			4.4%	1,351,671
ADAR1 Capital Management GP, LLC			4.3%	1,347,004
Daniel Schneeberger			4.4%	1,351,671
ADAR1 Partners, LP			4.3%	1,347,004
Perceptive Capital Solutions Corp 13G/A Amendment 1 PCSC · G70077105	PCSC	G70077105	5.1% Checked 5% or less	456,720	13G/A Amendment 1	2/17/2026 Event 12/31/2025
ADAR1 Capital Management, LLC			5.1%	456,720
ADAR1 Capital Management GP, LLC			4.5%	402,925
Daniel Schneeberger			5.1%	456,720
Grace Therapeutics, Inc. 13G/A Amendment 4 GRCE · 00439U104	GRCE	00439U104	9.9%	1,648,791	13G/A Amendment 4	2/17/2026 Event 12/31/2025
ADAR1 Capital Management, LLC			9.9%	1,646,173
ADAR1 Capital Management GP, LLC			9.9%	1,648,791
Daniel Schneeberger			9.9%	1,646,173
Prothena Corporation Public Limited Company 13G/A Amendment 1 PRTA · G72800108	PRTA	G72800108	2.7%	1,469,098	13G/A Amendment 1	11/14/2025 Event 9/30/2025
ADAR1 Capital Management, LLC			2.7%	1,469,098
ADAR1 Capital Management GP, LLC			2.2%	1,189,587
Daniel Schneeberger			2.7%	1,469,098
Equillium, Inc. 13G EQ · 29446K106	EQ	29446K106	9.9%	6,194,882	13G	11/14/2025 Event 9/30/2025
ADAR1 Capital Management, LLC			9.9%	6,117,290
ADAR1 Capital Management GP, LLC			9.9%	6,194,882
Daniel Schneeberger			9.9%	6,117,290
Grace Therapeutics, Inc. 13G/A Amendment 3 ACST · 00430K865	ACST	00430K865	9.9%	1,534,254	13G/A Amendment 3	11/14/2025 Event 9/30/2025
ADAR1 Capital Management, LLC			9.9%	1,529,200
ADAR1 Capital Management GP, LLC			9.9%	1,534,254
Daniel Schneeberger			9.9%	1,529,200
Keros Therapeutics, Inc. 13D/A Amendment 5 KROS · 492327101	KROS	492327101	0%	0	13D/A Amendment 5	10/15/2025 Event 10/15/2025
ADAR1 Capital Management, LLC			0%	0
ADAR1 Capital Management GP, LLC			0%	0
Daniel Schneeberger			0%	0
Keros Therapeutics, Inc. 13D/A Amendment 4 KROS · 492327101	KROS	492327101	13.3%	5,389,264	13D/A Amendment 4	8/21/2025 Event 8/21/2025
ADAR1 Capital Management, LLC			13.3%	5,389,264
ADAR1 Capital Management GP, LLC			11.4%	4,645,906
Daniel Schneeberger			13.3%	5,389,264
iBio, Inc. 13G/A Amendment 3 IBIO · 451033708	IBIO	451033708	9.9%	1,794,055	13G/A Amendment 3	8/14/2025 Event 6/30/2025
ADAR1 Capital Management, LLC			9.9%	1,794,055
ADAR1 Capital Management GP, LLC			9.9%	1,794,055
Daniel Schneeberger			9.9%	1,794,055
Inhibikase Therapeutics, Inc. 13G/A Amendment 1 IKT · 45719W205	IKT	45719W205	9.9%	7,737,694	13G/A Amendment 1	8/14/2025 Event 6/30/2025
ADAR1 Capital Management, LLC			9.9%	7,682,503
ADAR1 Capital Management GP, LLC			9.9%	7,737,694
Daniel Schneeberger			9.9%	7,682,503
Prothena Corporation Public Limited Company 13G PRTA · G72800108	PRTA	G72800108	6.3%	3,375,009	13G	8/14/2025 Event 6/30/2025
ADAR1 Capital Management, LLC			6.3%	3,375,009
ADAR1 Capital Management GP, LLC			5.4%	2,892,995
Daniel Schneeberger			5.4%	2,892,995
BioAge Labs, Inc. 13G BIOA · 09077V100	BIOA	09077V100	5.4%	1,937,123	13G	8/14/2025 Event 6/30/2025
ADAR1 Capital Management, LLC			5.4%	1,937,123
Daniel Schneeberger			5.4%	1,937,123
Kiora Pharmaceuticals, Inc. 13G/A Amendment 1 KPRX · 49721T507	KPRX	49721T507	9.9%	365,179	13G/A Amendment 1	8/14/2025 Event 6/30/2025
ADAR1 Capital Management, LLC			9.9%	362,527
ADAR1 Capital Management GP, LLC			9.9%	365,179
Daniel Schneeberger			9.9%	362,527
Cellectar Biosciences, Inc. 13G/A Amendment 2 CLRB · 15117F500	CLRB	15117F500	0.1%	2,962	13G/A Amendment 2	8/14/2025 Event 6/30/2025
ADAR1 Capital Management, LLC			0.1%	2,962
ADAR1 Capital Management GP, LLC			0.1%	2,540
Daniel Schneeberger			0.1%	2,962
ADAR1 Partners, LP			0%	0
Grace Therapeutics, Inc. 13G/A Amendment 2 ACST · 00430K865	ACST	00430K865	10.0%	1,502,143	13G/A Amendment 2	5/15/2025 Event 3/31/2025
ADAR1 Capital Management, LLC			10.0%	1,501,473
ADAR1 Capital Management GP, LLC			10.0%	1,502,143
Daniel Schneeberger			10.0%	1,501,473
Keros Therapeutics, Inc. 13D/A Amendment 3 KROS · 492327101	KROS	492327101	13.3%	5,390,964	13D/A Amendment 3	5/12/2025 Event 5/12/2025
ADAR1 Capital Management, LLC			13.3%	5,390,964
ADAR1 Capital Management GP, LLC			11.4%	4,647,406
Daniel Schneeberger			13.3%	5,390,964
Keros Therapeutics, Inc. 13D/A Amendment 2 KROS · 492327101	KROS	492327101	13.3%	5,390,964	13D/A Amendment 2	5/8/2025 Event 5/8/2025
ADAR1 Capital Management, LLC			13.3%	5,390,964
ADAR1 Capital Management GP, LLC			11.4%	4,647,406
Daniel Schneeberger			13.3%	5,390,964
Keros Therapeutics, Inc. 13D/A Amendment 1 KROS · 492327101	KROS	492327101	13.3%	5,390,964	13D/A Amendment 1	4/28/2025 Event 4/24/2025
ADAR1 Capital Management, LLC			13.3%	5,390,964
ADAR1 Capital Management GP, LLC			11.5%	4,647,406
Daniel Schneeberger			13.3%	5,390,964
Keros Therapeutics, Inc. 13D KROS · 492327101	KROS	492327101	13.3%	5,390,964	13D	4/11/2025 Event 4/4/2025
ADAR1 Capital Management, LLC			13.3%	5,390,964
ADAR1 Capital Management GP, LLC			11.5%	4,647,406
Daniel Schneeberger			13.3%	5,390,964
iBio, Inc. 13G/A Amendment 2 IBIO · 451033708	IBIO	451033708	10.0%	1,095,967	13G/A Amendment 2	2/14/2025 Event 12/31/2024
ADAR1 Capital Management, LLC			10.0%	1,095,967
ADAR1 Capital Management GP, LLC			10.0%	1,095,967
Daniel Schneeberger			10.0%	1,095,967
Zura Bio Limited 13G/A Amendment 1 ZURA · G9TY5A101	ZURA	G9TY5A101	3.2%	2,077,251	13G/A Amendment 1	2/14/2025 Event 12/31/2024
ADAR1 Capital Management, LLC			3.2%	2,077,251
ADAR1 Capital Management GP, LLC			2.4%	1,578,787
Daniel Schneeberger			3.2%	2,077,251
Inhibikase Therapeutics, Inc. 13G IKT · 45719W205	IKT	45719W205	10.0%	6,994,246	13G	2/14/2025 Event 12/31/2024
ADAR1 Capital Management, LLC			10.0%	6,809,355
ADAR1 Capital Management GP, LLC			10.0%	6,994,246
Daniel Schneeberger			10.0%	6,809,355
KALA BIO, Inc. 13G/A Amendment 1 KALA · 483119202	KALA	483119202	4.9%	298,955	13G/A Amendment 1	2/14/2025 Event 12/31/2024
ADAR1 Capital Management, LLC			4.9%	298,955
ADAR1 Capital Management GP, LLC			4.3%	260,182
Daniel Schneeberger			4.9%	298,955